Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5X82
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,516
Award facts
- Contract value 100% obligated
- $24,516.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24.5K delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL). The contract is structured as a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to this major pharmaceutical distributor. Performance will be completed by January 15, 2026, with fulfillment occurring at the company's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999.9 million through December 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen is a leading pharmaceutical distributor and healthcare solutions provider that supplies a comprehensive range of brand-name and generic medications, vaccines, and medical devices to federal agencies. The company has demonstrated extensive capability in fulfilling DLA medical procurement requirements through multiple competitive awards covering diverse therapeutic domains, including diabetes medications, specialty pharmaceuticals, and critical medical supplies. This delivery order for Zepbound, a diabetes medication, exemplifies the company's role as a critical vendor supporting military and federal healthcare systems' pharmaceutical supply needs.
Quick answers
Who was awarded contract SPE2DR26F5X82?
SPE2DR26F5X82 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F5X82 worth?
The government has obligated $24,516 on SPE2DR26F5X82.
Is contract SPE2DR26F5X82 an order under another contract?
Yes. SPE2DR26F5X82 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5X82 competed?
The extent of competition for SPE2DR26F5X82 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award